Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French University Hospital

被引:12
作者
Benoist, H. [1 ]
Rodier, S. [1 ]
de La Blanchardiere, A. [2 ]
Bonhomme, J. [3 ]
Cormier, H. [2 ]
Thibon, P. [4 ]
Saint-Lorant, Guillaume [1 ]
机构
[1] Ctr Hosp Univ Caen, Pharm Cent, Serv Pharm, Ave Cote Nacre, F-14033 Caen 9, France
[2] Ctr Hosp Univ Caen, Serv Malad Infect, Caen 9, France
[3] Ctr Hosp Univ Caen, Microbiol Serv, Caen 9, France
[4] Ctr Hosp Univ Caen, CPias Normandie, Caen 9, France
关键词
Candidaemia; Prescribing practice; Antifungal stewardship; Fungal infections; BLOOD-STREAM INFECTION; ANTIMICROBIAL STEWARDSHIP; INVASIVE CANDIDIASIS; MANAGEMENT; CANDIDEMIA; EPIDEMIOLOGY; MORTALITY;
D O I
10.1007/s15010-018-01264-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectivesThe objective of this study was to compare clinical outcomes of patients with candidaemia before and after implementation of an antifungal stewardship program (AFSP).MethodsThis study included all consecutive cases of candidaemia identified from January 2012 to December 2015 in a French University Hospital. Data were collected retrospectively for a period of 2years before implementation of the AFSP, and prospectively for 2years after. All cases were reviewed by a multidisciplinary panel of experts including infectiologists, a microbiologist and pharmacists to have a complete follow-up of patients.Results33 and 37 patients were finally included in the first and second period, respectively. The sites of entry of the candidaemia cases studied were as follows: intraabdominal in 29 cases (41.4%), central venous catheter 21 (30.0%), other or unknown: 20 (28.6%). Infectiologist consultations increased from 36.4 to 86.5% between the two periods with a significative impact on daily blood cultures which were more frequently performed in the second period (p=0.04), and the use of echinocandins which was more frequent in the second period (97.1% of cases vs 78.8%, p=0.03). The 3-month mortality rate declined from 36.4% in the first period to 27.0% in the second period (p=0.4).ConclusionsDespite the insufficient number of candidaemia cases and the presence of other unmodifiable risk factors of mortality which did not allow us to show a significant effect on the 3-month mortality, AFSP had a significant effect on daily blood cultures and echinocandin use as first-line therapy.
引用
收藏
页码:435 / 440
页数:6
相关论文
共 21 条
[1]   The role of the multidisciplinary team in antifungal stewardship [J].
Agrawal, Samir ;
Barnes, Rosemary ;
Bruggemann, Roger J. ;
Rautemaa-Richardson, Riina ;
Warris, Adilia .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 :37-42
[2]   Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 [J].
Almirante, B ;
Rodríguez, D ;
Park, BJ ;
Cuenca-Estrella, M ;
Planes, AM ;
Almela, M ;
Mensa, J ;
Sanchez, F ;
Ayats, J ;
Gimenez, M ;
Saballs, P ;
Fridkin, SK ;
Morgan, J ;
Rodriguez-Tudela, JL ;
Warnock, DW ;
Pahissa, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) :1829-1835
[3]   Impact of an Antimicrobial Stewardship Program Comprehensive Care Bundle on Management of Candidemia [J].
Antworth, Allen ;
Collins, Curtis D. ;
Kunapuli, Anjly ;
Klein, Kristin ;
Carver, Peggy ;
Gandhi, Tejal ;
Washer, Laraine ;
Nagel, Jerod L. .
PHARMACOTHERAPY, 2013, 33 (02) :137-143
[4]   Impact of Education and an Antifungal Stewardship Program for Candidiasis at a Thai Tertiary Care Center [J].
Apisarnthanarak, Anucha ;
Yatrasert, Apiwat ;
Mundy, Linda M. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (07) :722-727
[5]   Population-Based Analysis of Invasive Fungal Infections, France, 2001-2010 [J].
Bitar, Dounia ;
Lortholary, Olivier ;
Le Strat, Yann ;
Nicolau, Javier ;
Coignard, Bruno ;
Tattevin, Pierre ;
Che, Didier ;
Dromer, Francoise .
EMERGING INFECTIOUS DISEASES, 2014, 20 (07) :1149-1155
[6]   Effects of nosocomial candidemia on outcomes of critically ill patients [J].
Blot, SI ;
Vandewoude, KH ;
Hoste, EA ;
Colardyn, FA .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (06) :480-485
[7]   ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients [J].
Cornely, O. A. ;
Bassetti, M. ;
Calandra, T. ;
Garbino, J. ;
Kullberg, B. J. ;
Lortholary, O. ;
Meersseman, W. ;
Akova, M. ;
Arendrup, M. C. ;
Arikan-Akdagli, S. ;
Bille, J. ;
Castagnola, E. ;
Cuenca-Estrella, M. ;
Donnelly, J. P. ;
Groll, A. H. ;
Herbrecht, R. ;
Hope, W. W. ;
Jensen, H. E. ;
Lass-Floerl, C. ;
Petrikkos, G. ;
Richardson, M. D. ;
Roilides, E. ;
Verweij, P. E. ;
Viscoli, C. ;
Ullmann, A. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 :19-37
[8]  
Davey P, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub3]
[9]   Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies [J].
Falagas, M. E. ;
Apostolou, K. E. ;
Pappas, V. D. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (07) :419-425
[10]   Success stories of implementation of antimicrobial stewardship: a narrative review [J].
Huttner, B. ;
Harbarth, S. ;
Nathwani, D. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) :954-962